Company · CIK 0001404644
Neurogene Inc.
NGNESearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$25.14−$0.86 (−3.31%)
NGNE · Last trade
- Prev close
- $26.00
- Range (29d)
- $21.56 – $30.42
On the record
Recent filings
- SCHEDULE 13GNGNENeurogene Inc.0001137774-26-000205 · 7.9 KBSEC(opens sec.gov)
- SCHEDULE 13GNGNENeurogene Inc.0000053417-26-000058 · 6.7 KBSEC(opens sec.gov)
- SCHEDULE 13G/ANGNENeurogene Inc.0001104659-26-097193 · 13.1 KBSEC(opens sec.gov)
- SCHEDULE 13G/ANGNENeurogene Inc.0001493152-26-038383 · 12.1 KBSEC(opens sec.gov)
- SCHEDULE 13GNGNENeurogene Inc.0001172661-26-003430 · 15.1 KBSEC(opens sec.gov)
- 10-QNGNEQuarterly update0001404644-26-000059 · 8.1 MBSEC(opens sec.gov)
- 8-KNGNECurrent report0001404644-26-000056 · 8.8 MBSEC(opens sec.gov)
- 8-KNGNECurrent report0001404644-26-000050 · 728.7 KBSEC(opens sec.gov)
- 8-KNGNECurrent report0001404644-26-000046 · 5.7 MBSEC(opens sec.gov)
- 8-KNGNECurrent report0001404644-26-000044 · 5.0 MBSEC(opens sec.gov)
Insiders
- 667, L.P.Director, Former 10% Owner
- AKKARAJU SRINIVAS10% Owner
- Alam KamranCFO, Vice President Finance
- Babler MartinDirector
- BAFFI ROBERTDirector
- Baker Bros. Advisors (GP) LLCDirector, Former 10% Owner
- BAKER BROS. ADVISORS LPDirector, Former 10% Owner
- Baker Brothers Life Sciences LPDirector, Former 10% Owner
- BAKER FELIXDirector, Former 10% Owner
- BAKER JULIANDirector, Former 10% Owner
Tickers
Addresses
business
535 W 24TH STREET 5TH FLOOR
NEW YORK, NY, 10011
mailing
535 W 24TH STREET 5TH FLOOR
NEW YORK, NY, 10011
Former names
- Neoleukin Therapeutics, Inc.2023-12-06
- AQUINOX PHARMACEUTICALS, INC2019-08-12
- AQUINOX PHARMACEUTICALS (USA) INC2013-12-24
Same industry